A Focus on MSI-high/ TMB-high Cancers and Biomarkers

TBA | 
Hybrid | VIRTUAL AND New York, NY 

Join SITC and a panel of experts for an afternoon of in-depth education on all aspects MSI-high/ TMB-high Cancers and Biomarkers.

Program Agenda - Coming Soon

Target Audience

The Advances in Cancer Immunotherapy™ (ACI) programs aim to reach practicing clinical oncologists, nurses, nurse practitioners, advanced practitioners, pharmacists, emergency physicians, and other allied health professionals who wish to learn the basic principles of cancer immunotherapy and the most up-to-date clinical data for these treatments, in a multitude of disease states/therapeutic areas, in order to inform and integrate into their own clinical practice. In-training oncologists and hospital administrators will also find the program beneficial.

Case Study Submission Information

As part of the program, registrants are encouraged to submit case studies for expert review during the case study panel concluding the program. If you are interested in taking advantage of this opportunity, please review and sign the linked case study guidelines, and return your case study and signed guidelines to education@sitcancer.org.

Program Learning ObjectiveS

  • Discuss biomarkers in clinical use with cancer immunotherapies and their relevance to the cancer immunotherapy approaches in use for the treatment of MSI-H/TMB-H cancers.

  • Summarize recent updates in the use of biomarkers for cancer immunotherapies and of cancer immunotherapy for MSI-H/TMB-H cancers including emerging toxicities and management.

  • Implement the use of biomarkers to select appropriate immunotherapy for cancers, including MSI-H/TMB-H cancers.

  • Describe the rationale for the use of cancer immunotherapy in MSI-H/TMB-H cancers.

Joint Accreditation Statement

thumbnail image In support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical Education (PACE) and the Society for Immunotherapy of Cancer (SITC).  PACE is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

Credit information to be determined

Continuing Pharmacy Education

Credit information to be determined.

Continuing Nursing Education

Credit information to be determined.



American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC)

Credit information to be determined. ABIM_Logo.jpg





Disclosure of Conflicts of Interest

PACE requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial relationships they may have with ineligible companies. All relevant financial relationships are thoroughly vetted and mitigated according to PACE policy. PACE is committed to providing learners with high-quality accredited CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Avoid Fraudulent ACI Registration Websites

Recently, the SITC office received communication about a fraudulent registration website for one of our ACI programs. To help ensure others don’t mistakenly register on an unauthorized, third-party website, we're proactively informing you to ensure you’re able to safely register for the event through the official SITC website, and so that you can confirm the communication you receive is truly from SITC.

All official forthcoming ACI registration information will come from an email address ending in @sitcancer.org. If you have any questions, please contact the SITC office at events@sitcancer.org or 414-271-2456.

Americans with Disabilities Act

Event staff will be glad to assist you with any special needs (i.e., physical, dietary, etc). Please contact SITC Staff prior to the live event at (414) 271-2456 or via email education@sitcancer.org.